Araştırma Makalesi


DOI :10.26650/IstanbulJPharm.2022.996448   IUP :10.26650/IstanbulJPharm.2022.996448    Tam Metin (PDF)

Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances

Cemre ÖzkancaSibel Döşler

Background and Aims: Recently, one of the biggest problems of the world is a bacterial antimicrobial resistance, that is developing against most of the existing antibiotics. In addition to conducting studies that continue to discover new antimicrobial agents for combating multidrug resistant bacteria, steps should be taken for the protection of existing antibiotics. With this in mind, many modern and classical strategies have been developed, and among them, using essential oils or extracts obtained from plants, which may be a practical and effective alternative. Methods: We used the experimental evolutionary microbiology method to determine the effects of herbal substances, such as cinnamaldehyde from cinnamon, epigallocatechin gallate from greentea, curcumin from turmeric, punicalagin from pomegranate, and clove oil from clove, on the prevention or delay of antimicrobial resistance. In this study, Staphylococcus aureus and Escherichia coli standard and clinical strains were gradually exposed to increasing sub-inhibitory concentrations of meropenem and ciprofloxacin with or without the presence of herbal substances. Results: Resistance was developed in the E. coli and S. aureus control groups which were exposed only to ciprofloxacin, but, when herbal substances were included to the test, there was no resistance development. When the control groups were exposed only to meropenem, there was only an increase in the minimum inhibitory concentrations (MIC), but they did not become resistant, and we observed similar MIC values when we added the herbal substances to the test. Conclusion: These results showed that herbal substances might contribute to lowering MIC values of antibiotics and may help prevent the development of resistance in the studied bacteria.


PDF Görünüm

Referanslar

  • Allen, R. C., Popat, R., Diggle, S. P., & Brown, S. P. (2014). Targeting virulence: Can we make evolution-proof drugs? Nature reviews Microbiology, 12(4), 300-308. https://doi.org/10.1038/ nrmicro3232 google scholar
  • Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., Salamat, M., & Baloch, Z. (2018). Antibiotic resistance: A rundown of a global crisis. Infection and Drug Resistance, 11, 1645-1658. https://doi:10.2147/IDR.S173867 google scholar
  • European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID). (2003). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clinical Microbiology and Infection, 9(8), 1-7. https://doi. org/10.1046/j.1469-0691.2003.00790.x google scholar
  • European Committee on Antimicrobial Susceptibility Testing. (2021). Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0, 2021. Retrieved from: http://www.eucast.org google scholar
  • Fröhlich, C., Gama, J. A., Harms, K., Hirvonen, V., Lund, B. A., van der Kamp, M. W., Johnsen, P, J., Samuelsen, 0., &Leiros, H. S. (2021). Cryptic p-Lactamase Evolution Is Driven by Low p-Lactam Concentrations. mSphere, 6(2), e00108-21. https://doi. org/10.1128/mSphere.00108-21 google scholar
  • Hassanzadeh, S., Mashhadi, R., Yousefi, M., Askari, E., Saniei, M., &Pourmand, M. R. (2017). Frequency of efflux pump genes mediating ciprofloxacin and antiseptic resistance in methicillin-resistant Staphylococcus aureus isolates. Microbial Pathogenesis, 111, 71-74. https://doi.org/10.1016/j.micpath.2017.08.026 google scholar
  • Hitzenbichler, F., Simon, M., Holzmann, T., Iberer, M., Zimmermann, M., Salzberger, B., & Hanses, F. (2018). Antibiotic resistance in E. coli isolates from patients with urinary tract infections presenting to the emergency department. Infection, 46(3), 325-331. https://doi. org/10.1007/s15010-018-1117-5 google scholar
  • Hong, T., Moland, E. S., Abdalhamid, B., Hanson, N. D., Wang, J., Sloan, C., Fabian, D., Farajallah, A., Levine, J., & Thomson, K. S. (2005). Escherichia coli: development of carbapenem resistance during therapy. Clinical Infectious Diseases, 40(10), e84-e86. https://doi.org/10.1086/429822 google scholar
  • Hooper D. C. (2001). Emerging mechanisms of fluoroquinolone resistance. Emerging Infectious Diseases, 7(2), 337-341. https://doi. org/10.3201/eid0702.010239 google scholar
  • Hu, Q., Zhou, M., & Wei, S. (2018). Progress on the Antimicrobial Activity Research of Clove Oil and Eugenol in the Food Antisepsis Field. Journal of food science, 83(6), 1476-1483. https://doi. org/10.1111/1750-3841.14180 google scholar
  • Johnson, P. J., & Levin, B. R. (2013). Pharmaco-dynamics, population dynamics, and the evolution of persistence in Staphylococcus aureus. PLOS Genetics, 9(1), e1003123. https://doi.org/10.1371/ journal.pgen.1003123 google scholar
  • Koksal, F., Ak, K., Kucukbasmaci, O., &Samasti, M. (2009). Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital. Chemotherapy, 55(4), 293-297. https://doi. org/10.1159/000224657 google scholar
  • Kunz, A. N., & Brook, I. (2010). Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy, 56(6), 492-500. https://doi.org/10.1159/000321018 google scholar
  • Lemaire, S., Van Bambeke, F., Mingeot-Leclercq, M. P., Glupczynski, Y., &Tulkens, P. M. (2007). Role of acidic pH in the susceptibility of intraphagocytic methicillin-resistant Staphylococcus aureus strains to meropenem and cloxacillin. Antimicrobial Agents and Chemotherapy, 51(5), 1627-1632. https://doi.org/10.1128/ AAC.01192-06 google scholar
  • Long, A., Liti, G., Luptak, A., & Tenaillon, O. (2015). Elucidating the molecular architecture of adaptation via evolve and resequence experiments. Nature Reviews Genetics, 16(10), 567-582. https:// doi.org/10.1038/nrg3937 google scholar
  • Matange N, Hegde S &Bodkhe S. (2019). Adaptation through lifestyle switching sculpts the fitness landscape of evolving populations: implications for the selection of drug-resistant bacteria at low drug pressures. Genetics, 211, 1029-1044. https:// doi.org/10.1534/genetics.119.301834 google scholar
  • McDonald M. J. (2019). Microbial Experimental Evolution - a proving ground for evolutionary theory and a tool for discovery. EMBO Reports, 20(8), e46992. https://doi.org/10.15252/ embr.201846992 google scholar
  • Odds F. C. (2003). Synergy, antagonism, and what the chequerboard puts between them. The Journal of Antimicrobial Chemotherapy, 52(1), 1. https://doi.org/10.1093/jac/dkg301 Vasconcelos, N. G., Croda, J., &Simionatto, S. (2018). Antibacterial mechanisms of cinnamon and its constituents: A review. Microbial pathogenesis, 120, 198-203. https://doi.org/10.1016/j.micpath.2018.04.036 google scholar
  • Pan S. Y., Zhou S. F., Gao S. H., Yu Z. L., Zhang S. F., Tang M. K., Sun J. N., Ma D. L., Han Y. F., Fong W. F.,& Ko K. M. (2013). New Perspectives on how to discover drugs from herbal medicines: CAM’s outstanding contribution to modern therapeutics. Evidence-Based Complementary and Alternative Medicine, 2013(1),1-25. https://doi.org/10.1155/2013/627375 google scholar
  • Pillai, S.K., Moellering, R.C.,& Eliopoulos, G.M. (2005) Antimicrobial combinations. In V. Lorian (Ed.), Antibiotics in Laboratory Medicine(5th ed.) (pp. 365-440). Philadelphia, PA: The Lippincott Williams & Wilkins Co. google scholar
  • Renzetti, A., Betts, J. W., Fukumoto, K., & Rutherford, R. N., (2020). Antibacterial green tea catechins from a molecular perspective: mechanisms of action and structure-activity relationships. Food & function, 11(11), 9370-9396. https://doi.org/10.1039/d0fo02054k World Health Organization (2021). Antimicrobial resistance. Retrieved from: https://www.who.int/en/news-room/fact-sheets/detail/antimicrobial-resistance google scholar
  • Xu, Y., Shi, C., Wu, Q., Zheng, Z., Liu, P., Li, G., Peng, X.,& Xia, X. (2017). Antimicrobial Activity of Punicalagin Against Staphylococcus aureus and Its Effect on Biofilm Formation. Foodborne pathogens and disease, 14(5), 282-287. https://doi.org/10.1089/ fpd.2016.2226 google scholar
  • Yap, P. S., Yiap, B. C., Ping, H. C., & Lim, S. H. (2014). Essential oils, a new horizon in combating bacterial antibiotic resistance. The Open Microbiology Journal, 8, 6-14. https://doi. org/10.2174/1874285801408010006 google scholar
  • Zheng, D., Huang, C., Huang, H., Zhao, Y., Khan, M., Zhao, H., & Huang, L. (2020). Antibacterial Mechanism of Curcumin: A Review. Chemistry & Biodiversity, 17(8), e2000171. https://doi. org/10.1002/cbdv.202000171 google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Özkanca, C., & Döşler, S. (2022). Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances. İstanbul Journal of Pharmacy, 52(2), 173-178. https://doi.org/10.26650/IstanbulJPharm.2022.996448


AMA

Özkanca C, Döşler S. Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances. İstanbul Journal of Pharmacy. 2022;52(2):173-178. https://doi.org/10.26650/IstanbulJPharm.2022.996448


ABNT

Özkanca, C.; Döşler, S. Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances. İstanbul Journal of Pharmacy, [Publisher Location], v. 52, n. 2, p. 173-178, 2022.


Chicago: Author-Date Style

Özkanca, Cemre, and Sibel Döşler. 2022. “Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances.” İstanbul Journal of Pharmacy 52, no. 2: 173-178. https://doi.org/10.26650/IstanbulJPharm.2022.996448


Chicago: Humanities Style

Özkanca, Cemre, and Sibel Döşler. Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances.” İstanbul Journal of Pharmacy 52, no. 2 (Feb. 2023): 173-178. https://doi.org/10.26650/IstanbulJPharm.2022.996448


Harvard: Australian Style

Özkanca, C & Döşler, S 2022, 'Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances', İstanbul Journal of Pharmacy, vol. 52, no. 2, pp. 173-178, viewed 1 Feb. 2023, https://doi.org/10.26650/IstanbulJPharm.2022.996448


Harvard: Author-Date Style

Özkanca, C. and Döşler, S. (2022) ‘Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances’, İstanbul Journal of Pharmacy, 52(2), pp. 173-178. https://doi.org/10.26650/IstanbulJPharm.2022.996448 (1 Feb. 2023).


MLA

Özkanca, Cemre, and Sibel Döşler. Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances.” İstanbul Journal of Pharmacy, vol. 52, no. 2, 2022, pp. 173-178. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2022.996448


Vancouver

Özkanca C, Döşler S. Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances. İstanbul Journal of Pharmacy [Internet]. 1 Feb. 2023 [cited 1 Feb. 2023];52(2):173-178. Available from: https://doi.org/10.26650/IstanbulJPharm.2022.996448 doi: 10.26650/IstanbulJPharm.2022.996448


ISNAD

Özkanca, Cemre - Döşler, Sibel. Prevention of antibiotic resistance created by experimental evolutionary microbiology in Staphylococcus aureus and Escherichia coli with herbal substances”. İstanbul Journal of Pharmacy 52/2 (Feb. 2023): 173-178. https://doi.org/10.26650/IstanbulJPharm.2022.996448



ZAMAN ÇİZELGESİ


Gönderim16.09.2021
Kabul27.03.2022
Çevrimiçi Yayınlanma29.08.2022

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.